V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159359 | 20061179 | 1.66 | 73.2 | Neo-adjuvant (N) | 2019-11-06 | 2019-11-18 | ECX | 2 | N | ECX | 100184168 |
| 20159360 | 20061180 | 1.55 | 80.6 | null | 2016-09-19 | 2016-10-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100651668 |
| 20159361 | 20061181 | 1.7 | 74 | Adjuvant (A) | 2019-10-28 | 2019-10-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100516349 |
| 20159363 | 20061182 | 1.46 | 58.8 | Palliative (P) | 2018-11-19 | 2018-12-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101428940 |
| 20159364 | 20061183 | 1.8 | 85.2 | Adjuvant (A) | 2017-06-13 | 2017-06-28 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100679052 |
| 20159366 | 20061184 | 1.59 | 78 | Adjuvant (A) | 2018-02-05 | 2018-02-19 | ECX | 02 | N | ECX | 100538065 |
| 20159367 | 20061185 | 1.8 | 88.4 | Palliative (P) | 2018-01-15 | 2018-01-15 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100307741 |
| 20159369 | 20061186 | 1.63 | 64 | Neo-adjuvant (N) | 2018-03-07 | 2018-03-24 | ECX | N | N | ECX | 100618559 |
| 20159371 | 20061187 | 1.75 | 50.1 | Palliative (P) | 2019-07-22 | 2019-08-10 | ECX | 02 | Y | ECX | 101800518 |
| 20159372 | 20061188 | 1.62 | 52.4 | Palliative (P) | 2017-08-17 | 2017-08-29 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101329059 |
| 20159373 | 20061189 | 1.59 | 64 | Neo-adjuvant (N) | 2019-07-03 | 2019-07-30 | ECX | N | N | ECX | 100250105 |
| 20159374 | 20061190 | 1.72 | 80.6 | Palliative (P) | 2019-05-12 | 2019-05-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101287073 |
| 20159376 | 20061191 | 1.75 | 80.4 | Curative (C) | 2018-02-28 | 2018-03-03 | ECX | N | N | ECX | 100815841 |
| 20159378 | 20061192 | 1.65 | 79.25 | Neo-adjuvant (N) | 2019-05-20 | 2019-06-02 | ECX | 02 | N | ECX | 101277418 |
| 20159380 | 20061193 | 1.79 | 37.8 | Palliative (P) | 2018-02-19 | 2018-04-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100007967 |
| 20159381 | 20061194 | 1.75 | 65.5 | Adjuvant (A) | 2017-01-17 | 2017-01-31 | ECX | N | N | ECX | 101707540 |
| 20159382 | 20061195 | 1.74 | 62.3 | Curative (C) | 2016-12-18 | 2016-12-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101832336 |
| 20159383 | 20061196 | 1.72 | 77.1 | Palliative (P) | 2018-12-03 | 2018-12-15 | ECX | N | N | ECX | 100033626 |
| 20159387 | 20061197 | 1.82 | 58.9 | null | null | 2018-06-11 | ECX | null | N | ECX | 100655723 |
| 20159388 | 20061198 | 1.54 | 75.05 | Neo-adjuvant (N) | 2018-03-25 | 2018-03-27 | ECX | 2 | N | ECX | 100274268 |
| 20159389 | 20061199 | 1.7 | 46 | Palliative (P) | 2017-11-13 | 2017-11-20 | ECX | N | N | ECX | 101248722 |
| 20159391 | 20061200 | 1.66 | 81.3 | Neo-adjuvant (N) | 2016-09-15 | 2016-09-30 | ECX | N | N | ECX | 101056533 |
| 20159393 | 20061201 | 1.84 | 69 | Palliative (P) | 2016-09-26 | 2016-10-16 | ECX | 02 | N | ECX | 101615542 |
| 20159394 | 20061202 | 1.73 | 52.3 | null | 2018-05-22 | 2018-06-11 | ECX | N | N | ECX | 101104356 |
| 20159395 | 20061203 | null | null | Palliative (P) | 2019-11-17 | 2019-11-17 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100115049 |
| 20159397 | 20061204 | 1.75 | 73.3 | Neo-adjuvant (N) | 2016-02-10 | 2016-02-16 | ECX | 2 | N | ECX | 101519675 |
| 20159398 | 20061205 | 1.72 | 77 | Neo-adjuvant (N) | 2017-03-25 | 2017-04-02 | ECX | 02 | N | ECX | 100191184 |
| 20159402 | 20061206 | 1.64 | 80.45 | Adjuvant (A) | 2017-07-06 | 2017-07-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101313072 |
| 20159404 | 20061207 | 1.8 | 42.7 | Adjuvant (A) | 2017-06-10 | 2017-06-22 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100839360 |
| 20159405 | 20061208 | 1.83 | 101.8 | Palliative (P) | 2016-05-21 | 2016-05-26 | ECX | N | N | ECX | 101039705 |
| 20159406 | 20061209 | 1.77 | 59.4 | Palliative (P) | 2017-11-18 | 2017-11-30 | ECX | 02 | N | ECX | 100517386 |
| 20159408 | 20061210 | 1.66 | 104.1 | Neo-adjuvant (N) | 2019-10-11 | 2019-10-23 | ECX | N | N | ECX | 100830191 |
| 20159410 | 20061211 | 1.64 | 125.15 | Curative (C) | 2016-03-29 | 2016-03-29 | ECX | N | Y | ECX | 100556130 |
| 20159412 | 20061212 | 1.74 | 70.8 | Adjuvant (A) | 2016-07-19 | 2016-07-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100912664 |
| 20159414 | 20061213 | 1.75 | 99 | Palliative (P) | 2016-06-13 | 2016-06-22 | ECX | 02 | N | ECX | 101307162 |
| 20159416 | 20061214 | 1.71 | 79.7 | null | 2019-01-02 | 2019-01-10 | ECX | 02 | N | ECX | 101814996 |
| 20159418 | 20061215 | 1.8 | 66.9 | Neo-adjuvant (N) | 2018-08-31 | 2018-09-15 | ECX | N | null | ECX | 101767260 |
| 20159419 | 20061216 | 1.76 | 94.6 | Curative (C) | 2019-12-09 | 2019-12-09 | ECX | N | N | ECX | 100467967 |
| 20159420 | 20061217 | 1.68 | 81.4 | Adjuvant (A) | 2020-01-14 | 2020-01-17 | ECX | 2 | N | CAPECITABINE + GEMCITABINE | 101556478 |
| 20159421 | 20061218 | 1.82 | 90 | Neo-adjuvant (N) | 2017-07-17 | 2017-08-01 | ECX | N | Y | ECX | 101296328 |
| 20159422 | 20061219 | 1.8 | 85.4 | Palliative (P) | 2015-11-08 | 2015-11-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100588952 |
| 20159423 | 20061220 | 1.66 | 64.7 | Neo-adjuvant (N) | 2018-08-04 | 2018-08-26 | ECX | N | N | ECX | 101738016 |
| 20159424 | 20061221 | 1.67 | 68.1 | Palliative (P) | 2017-01-27 | 2017-03-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100127852 |
| 20159425 | 20061222 | 1.55 | 73 | Adjuvant (A) | 2018-02-15 | 2018-02-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101448302 |
| 20159426 | 20061223 | 1.73 | 87.7 | Neo-adjuvant (N) | 2018-08-15 | 2018-08-15 | ECX | 02 | N | ECX | 101851381 |
| 20159429 | 20061224 | 1.7 | 62 | null | 2018-07-31 | 2018-08-14 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 101115089 |
| 20159430 | 20061225 | 1.54 | 72.8 | Palliative (P) | 2018-11-22 | 2018-11-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100300401 |
| 20159431 | 20061226 | 1.76 | 74.7 | Neo-adjuvant (N) | 2018-07-29 | 2018-08-09 | ECX | N | N | ECX | 100471041 |
| 20159433 | 20061227 | 1.64 | 63 | Adjuvant (A) | 2016-01-25 | 2016-02-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101104069 |
| 20159437 | 20061228 | 1.63 | 72.2 | Neo-adjuvant (N) | 2019-11-17 | 2019-11-24 | ECX | N | N | ECX | 100008623 |